ProKidney Corp.
PROK
$1.67
-$0.04-2.34%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -4.19% | -16.77% | 0.50% | 1.09% | 21.36% |
| Total Depreciation and Amortization | -9.74% | 9.80% | 14.20% | -8.44% | 1.65% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -13.71% | -21.17% | 9.25% | 7.28% | 29.29% |
| Change in Net Operating Assets | -793.92% | -41.86% | 168.85% | -269.90% | -93.66% |
| Cash from Operations | -28.21% | -22.25% | 15.34% | -6.16% | -22.43% |
| Capital Expenditure | 34.20% | -10.68% | -67.00% | -174.19% | 95.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 147.04% | -54.32% | 57.84% | -26.33% | -27.51% |
| Cash from Investing | 23.97% | -3.19% | 56.30% | -34.37% | 87.59% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 40.00% | -200.00% | 135.71% | -16.67% | 14.29% |
| Issuance of Common Stock | -98.76% | 121.71% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -98.78% | 121.50% | 56,964.29% | -16.67% | -109.76% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -150.26% | 27.27% | 180.71% | -878.33% | 85.34% |